BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15542180)

  • 1. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C; Bauche C; Ladant D; Leclerc C
    Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
    Simsova M; Sebo P; Leclerc C
    Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.
    Guermonprez P; Fayolle C; Rojas MJ; Rescigno M; Ladant D; Leclerc C
    Eur J Immunol; 2002 Nov; 32(11):3071-81. PubMed ID: 12385027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
    Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
    J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
    Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
    Préville X; Ladant D; Timmerman B; Leclerc C
    Cancer Res; 2005 Jan; 65(2):641-9. PubMed ID: 15695409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
    Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
    J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase toxin translocates across target cell membrane without forming a pore.
    Osickova A; Masin J; Fayolle C; Krusek J; Basler M; Pospisilova E; Leclerc C; Osicka R; Sebo P
    Mol Microbiol; 2010 Mar; 75(6):1550-62. PubMed ID: 20199594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
    Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
    Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
    Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C
    Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.
    Dadaglio G; Fayolle C; Zhang X; Ryffel B; Oberkampf M; Felix T; Hervas-Stubbs S; Osicka R; Sebo P; Ladant D; Leclerc C
    J Immunol; 2014 Aug; 193(4):1787-98. PubMed ID: 25024388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.